In fracture treatment, biological bone union generally depends on the bone's natural fracture healing capacity, even in surgically treated cases. Hydroxyapatite/collagen composite (HAp/Col) has high osteoconductivity and stimulates osteogenic progenitors. Furthermore, it has the potent capacity to adsorb bone morphogenetic proteins (BMPs). In this study, we prepared an injectable HAp/Col paste and evaluated its augmentation of bone union. Furthermore, the effect of HAp/Col paste combined with BMP-2 was also evaluated. We used a rat femur osteotomy model with a defect size of 1 mm. Male Wistar rats were assigned to one of the following four groups; a control group without any implant, a HAp/Col implant group, a group that received an absorbable collagen sponge (ACS) implant impregnated with BMP-2 (1 mg), and a group that received a HAp/Col implant impregnated with BMP-2 implant. Micro-CT analysis, three-point bending tests, and histological evaluation were performed. Bone union was achieved in two of eight cases in the HAp/Col group, five of eight cases in the ACS þ BMP-2 group, and all cases in the HAp/Col þ BMP-2 group at 8 weeks post-surgery. The control group did not achieve bone union. In addition, in the HAp/Col þ BMP-2 group, the biomechanical strength of the fused femurs was comparable to that of the contralateral intact femur; the ratio of the mechanical load at the breaking point of the osteotomy side relative to that of the contralateral side was 1.00 AE 0.151 (SD). These results indicate that HAp/Col paste with or without BMP-2 augments bone union. ß
Reduction and fixation are principal factors in the treatment of fractures. Therefore, most research concerning fracture treatment has focused on these factors. Once fixation is performed, bone union generally depends on the natural fracture healing process, which occurs via biological reactions at the fracture site. Complete bone union requires at least 4-6 weeks. This extensive healing process not only diminishes a patient's quality of life but can also cause economic loss. Recently, an increasing number of studies aiming to augment the bone union process have utilized scientific and technological advances in bone biology.
Low-intensity pulsed ultrasonography (LIPUS) was approved by the US Food and Drug Administration (FDA) in 1994 for fractures and has been used for promoting bone union by stimulating cellular responses at the fracture site. However, only potential efficacy has been shown for this intervention. 1 Electric stimulation (ESTIM) has also been developed based on a concept similar to that of LIPUS, and positive effects with a certain level of significance have been confirmed in the treatment of delayed union or nonunion. 2 Teriparatide (PTH ) is a genetically engineered analog of the human parathyroid hormone. Its anabolic effects augment bone formation by stimulating osteoblast activity, and teriparatide is thus used for the treatment of osteoporosis. 3 Antisclerostin antibodies also augment bone formation by neutralizing sclerostin, which inhibits Wnt signaling and consequently osteoblast activity. A clinical trial using this antibody to treat osteoporosis is currently in progress. 4, 5 Systemic administration of both drugs has been reported as effective for augmenting fracture healing in animals. 6, 7 Furthermore, teriparatide has been clinically proven to augment fracture healing under certain sets of conditions. 8 Growth factors, which stimulate cellular proliferation and/or differentiation, have also been shown to accelerate fracture healing. Mitogenic activity of basic fibroblast growth factor (bFGF) has been proven to be effective when combined with a proper carrier or other system for sustained release. 9, 10 Platelet-derived growth factors (PDGFs) from blood plasma have been used to augment bone formation and bone defect repair, especially in dentistry. 11 Among all available growth factors, bone morphogenetic proteins (BMPs) are thought to be the most promising. Some BMPs have potent osteoinductivity. Among them, BMP-2 was approved by the FDA for anterior lumbar interbody fusion in 2002. 12 Effectiveness of BMP-2 for fracture healing was also demonstrated, and it was approved for open tibial shaft fractures in 2004. 13, 14 Hydroxyapatite/collagen composite (HAp/Col), which is composed of nanoscale hydroxyapatite crystals and porcine atelocollagen, is a bio-absorbable material developed as a bone void filler. 15 The porous body of HAp/Col has been available as a bone substitute since 2012 in Japan. 16 Previously, when porous HAp/Col was implanted into a 5-mm bone hole created in rabbit tibiae, active bone formation was observed mainly inside the bone marrow cavity and progressed toward the cortical defect, although scarce bone formation was observed inside the bone marrow cavity of the control group without implantation. 17 Studies using a rabbit osteochondral defect model demonstrated an obvious augmentative effect of HAp/Col on bone formation inside the bone marrow cavity, which was also confirmed by quantitative analysis using micro CT imaging. 18, 19 From these observations, given the localization and nature of the bone regeneration, we speculate that bone marrow cells, most likely including stem and progenitor cells, react vigorously and promote active bone formation around and inside the HAp/Col implant. In addition to bone conductivity, HAp/Col adsorbs a large amount of BMPs and permits their sustained release. 19 Therefore, HAp/Col is a promising candidate as a BMP carrier for use in a clinical setting.
We hypothesized that HAp/Col would also stimulate bone marrow cells at fracture sites and consequently accelerate fracture healing. HAp/Col, which adsorbs BMP-2, also has other favorable effects on fracture healing. In this study, we evaluated the application of HAp/Col implantation with or without BMP-2 as an augmentation method for fracture healing. To explore its use in conservative treatments, we used an injectable HAp/Col paste. However, the actual implants were HAp/Col disks prepared by drying the HAp/Col paste to enable quantitative and well-defined experiments. To confirm the facilitation of fracture healing, we used a rat femur osteotomy model because rat osteotomy models have been used in many studies with various fixation methods.
MATERIALS AND METHODS

In Vitro Adsorption and Release of BMP-2
HAp/Col (20 mg) was placed in 15-ml tubes coated with 2-methacryloyloxyethyl phosphorylcholine (MPC). Then, rhBMP-2 solution (75 mg/120 ml) was mixed with HAp/Col in the tube. The rhBMP-2 was included in an Infuse 1 bone graft kit purchased from Medtronic (Minneapolis, MN). After incubation for an hour at 37˚C, 1 ml of fetal bovine serum (FBS) was added to the tube. The solution containing HAp/ Col was carefully mixed by repeated pipetting with an MPCcoated tip, followed by centrifugation at 3500 rpm for 5 min. All of the supernatant was aspirated, and the BMP-2 concentration was measured with an ELISA kit (R&D Systems, Minneapolis, MN). The amount of BMP-2 adsorbed on the HAp/Col was determined by subtracting the release of BMP-2 in the FBS from the total amount of applied BMP-2.
The release profile was continuously assessed following a previous adsorption experiment. The aspirated supernatant was replaced with 2.5 ml of FBS, and repetitive pipetting was performed to thoroughly mix the solution. The mixture was then incubated at 4˚C. Samples were collected at 0.5, 2, 24, 48, 72, and 120 h. Briefly, after centrifugation, all of the supernatant was collected for measurement of the BMP-2 concentration and was then replaced by 2.5 ml of FBS to measure the BMP-2 content released during the next interval. The BMP-2 concentration of each supernatant was measured using the same ELISA kit used in the adsorption study. For these assays, four samples were prepared, and the measurements were performed in duplicate. The standards for the ELISA assay were prepared using BMP-2 solutions dissolved in FBS from the same lot to control for potential effects of the FBS on the measurements.
Preparation of Implants
HAp/Col fibers were synthesized according to the method of Kikuchi et al. 15 HAp/Col paste was prepared by mixing 1 g of HAp/Col fibers and 3 ml of natural saline. The HAp/Col paste was injected into a cylindrical mold with a height of 1.5 mm and a diameter of 4 mm, which is similar to the dimensions of the femur shaft of the rats used in this study. The HAp/ Col paste was dried in a desiccator and shrank to a small hard disc (Fig. 1) .
Surgical Procedure
All animal experiments were performed after approval was obtained from the Animal Experiment Committee of Tokyo Medical and Dental University and were conducted according to the guidelines of our institution on the care and use of laboratory animals (0170348A). Wistar rats (male, 14-16 weeks old, 300-320 g) were anesthetized by inhalation of isoflurane. After the lateral side of the left thigh was shaved and disinfected, a longitudinal incision was made along the femur shaft. Then, the femur was approached through the intermuscular space between the biceps femoris and the vastus lateralis muscles, and the femur was exposed while preserving the periosteum attaching the femur. A polyetheretherketone (PEEK) plate (Fig. 2) was set on the lateral side of the femur and fixed using threaded stainless steel Kirschner wires (diameter: 1.4 mm) and stainless steel banding wires (diameter: 0.55 mm). Although the diameter of the K-wires and those of the holes of the plate were 1.4 mm, the holes were not threaded, which permitted reciprocal motion even for the threaded K-wires. However, the thickness of the plate was 3 mm and the length of the holes was 2.5 mm, which was sufficient to prevent wiper motion of the K-wires. Therefore, by fixing the plate attached to the bone tightly by banding wires, the reciprocal motion was inhibited and the fixation was considered to be rigid. Osteotomy was performed by irrigating natural saline at the center of the femur shaft, and the gap was adjusted to 1 mm (Fig. 2) . After the osteotomy, the osteotomy site was flushed with natural saline to remove debris. The rats were assigned to one of four treatment groups (n ¼ 8, total 32): the defect was left empty (control group), filled with a HAp/Col disc (HAp/Col group), filled with an absorbable collagen sponge (ACS, 4 Â 4 Â 4 mm) impregnated with 1.0 mg of recombinant human BMP-2 (10 ml of BMP-2 solution [100 mg/ml]; ACS þ BMP-2) or filled with a HAp/Col disc impregnated with 1.0 mg of rhBMP-2 (HAp/ Col þ BMP-2). During the implantations for the HAp/Col group, the HAp/Col disks absorbed blood from the surrounding tissue, including bone marrow, and softened and swelled to fit the bone defect. The ACS impregnated with BMP-2 solution shrank to approximately the same size as the bone defect. The HAp/Col disks of the HAp/Col þ BMP-2 group were softened and swelled sufficiently to fill the defect upon impregnation with BMP-2 solution. The ACS used in the study was also included in the Infuse 1 bone graft kit. After surgery, the rats were able to move freely without any limitations in a SPF level cage (2 rats/cage).
Micro-CT Analysis
In vivo micro-CT images were acquired each week using a micro-CT system (CosmoScan GX, Rigaku Co., Tokyo, Japan) under general anesthesia by inhalation of isoflurane. At 8 weeks after surgery, the rats were sacrificed with an overdose of sodium pentobarbital, the femurs were harvested, and the stainless steel wires were removed. Then, a micro-CT scan of the specimens was performed to obtain finer and higher resolution images compared to those obtained before harvesting. Quantification of bone tissue at the osteotomy sites including 1 mm proximal and distal regions (the total length of the evaluated region was 3 mm) was performed using image analysis software (TRI/3D-BON; Ratoc System Engineering Co., Tokyo, Japan).
Biomechanical Testing
At 8 weeks after surgery, the femurs were harvested. After the PEEK plate and wires were removed from the harvested femur, manual palpation was performed to determine whether the osteotomy site was fused. Femurs that were considered to be fused underwent a three-point bending test using a testing machine (MTS Mini Bionix II, MTS Systems Co., Eden Prairie, MN). Two supporting points were placed at an interval of 1 cm apart, and the load was applied at the center of the interval using an indenter with a crosshead speed of 0.5 mm/sec until the specimen was broken. The femur was mounted in the AP position, and the osteotomy site was shifted 0.5 mm from the center of the interval so that it would not be directly pushed by the indenter (Fig. 3) . As a control, biomechanical testing of the contralateral femur was also performed.
Histological Evaluation
Following the micro-CT analysis and biomechanical testing, the harvested femurs were fixed in 4% paraformaldehyde for a week at 4˚C. Then, the tissues were decalcified in 10% EDTA solution for 2 weeks at room temperature. After decalcification, they were washed with tap water, dehydrated in ethanol, cleared with xylene, and embedded in paraffin. The specimens were coronally sectioned with a thickness of 5 mm through the center of the diaphysis. The thin sections were stained with hematoxylin and eosin and observed using bright-field microscopy.
Statistics
After confirmation of the normal distribution and homogeneity of variance of the data, overall differences among groups in the biomechanical test were determined by a one-way analysis of variance (ANOVA) followed by multiple-comparison testing using the Tukey Kramer test. All data are presented as the mean and standard deviation (SD). p < 0.05 was considered significant.
RESULTS
Adsorption of BMP-2 on HAp/Col and Release of BMP-2 From HAp/Col
The amount of BMP-2 retained on 20 mg of HAp/Col was 66.6 mg, indicating that 1 g of HAp/Col adsorbed 3.33 mg of BMP-2. The release ratio of BMP-2 relative to the total amount of retained BMP-2 at each time point (30 min, 120 min, 24 h, 48 h, 72 h, and 120 h) was 11.4%, 7.5%, 4.2%, 1.9%, 1.1%, and 0.83%, respectively. The cumulative release rate indicated a long and slow release of BMP-2 from the HAp/Col, which showed only a 19% release of BMP-2 in the initial 120 min, followed by a slight release after 24 h (Fig. 4) .
Micro-CT
Micro CT images of all cases at 8 weeks are shown in Figure 5 (n ¼ 8). Longitudinal in vivo micro CT images of a representative case from each group are shown in Figure 6 and the micro-CT images of the harvested specimens are shown in Figure 7 . In the control group, at 2-3 weeks after surgery, a small amount of callus formation was observed at the osteotomy sites. Then, approximately 6 weeks after surgery, atrophy of the osteotomy stumps was observed. As a result, none of the femurs achieved synostosis. Regarding the stability of the fixation, we could not detect obvious mobility in the CT analysis, even in the control group. Most of the HAp/Col group showed more callus formation than the control group, primarily in the bone marrow cavity at 2-3 weeks. However, only two of eight cases achieved bone union at 8 weeks after surgery. In the ACS þ BMP-2 group, all cases showed transient callus formation at the osteotomy site 2-3 weeks after surgery. At 8 weeks after surgery, five of eight cases developed bone bridging at the osteotomy sites. All cases of the HAp/Col þ BMP-2 group exhibited callus formation at the osteotomy site at 2-3 weeks after surgery, and the extent of callus formation was larger than that of the ACS þ BMP-2 group. At 8 weeks after surgery, all cases achieved bone bridging. Quantitative analysis demonstrates superior osteogenic ability of BMP-2 in both the ACS þ BMP group and HAp/Col þ BMP group. In the HAp/Col group, although non-union was noticeable, augmentation of bone formation was confirmed compared to the control group (Fig. 8) .
Biomechanical Testing
At 8 weeks after surgery, all femurs were harvested and submitted to manual palpation. Plate fixation of each harvested femur was sufficiently rigid without laxity. The results of the manual palpation following removal of the plate fixation were consistent with the findings of the CT analyses ( Table 1 ). The tissues determined to be fused by manual palpation were submitted to a three-point bending test (HAp/Col: two cases; ACS þ BMP: five cases; HAp/Col þ BMP: eight cases). Figure 9 shows the average ratio of the mechanical load at the breaking point for the experimental side compared to that of the intact femur of the contralateral side in each rat. There were no significant differences among the groups, although the sample number of each group varied.
Histological Findings
In the control group, the intervening bone marrow cavity between the second and third Kirschner wires, including the osteotomy site, was filled with fibrous tissue and some newly formed bone. Neighboring normal bone marrow and fibrous tissue were observed bordering the Kirschner wires. In some specimens, both newly formed bone and atrophy of the cortical bone were observed at the bone stumps (Fig. 10A) . In other specimens, newly formed bone at the bone stumps almost closed the bone marrow cavities. In the HAp/Col group, most of the femurs did not achieve bone union, although the amount of newly formed bone in the bone marrow cavity and the osteotomy site was larger than that of the control group (Fig. 10B) . In the non-union cases with little bone formation, the bone marrow cavity was primarily filled with fibrous tissue, as observed for the control group. In contrast, the non-union cases with relatively abundant bone formation showed recovery of normal bone marrow ( Fig. 10B and E) . Remnants of HAp/Col were not observed in any specimens. In the ACS þ BMP-2 group, the non-union cases showed relatively more bone formation than the control group. However, the bone marrow cavity was filled with fibrous tissue, as observed for the control. In the union cases, the cortical bone was bridged by crude bone tissue and the recovery of the normal bone marrow cavity progressed (Fig. 10C ). In the HAp/Col þ BMP-2 cases, all femurs achieved bone union. The edge of the cortical bone was bridged by crude bone tissue, and the bone marrow cavity was filled with almost normal bone marrow ( Fig. 10D and F) .
DISCUSSION
This study was conducted to evaluate the effects of HAp/Col paste implantation on bone union with the expectation that HAp/Col with strong osteoconductivity would stimulate osteogenic activity in the surrounding cells and consequently augment bone union. In addition, as HAp/Col has been confirmed as a promising BMP carrier, we also evaluated the HAp/ Col paste combined with BMP-2 as a bone union accelerator compared to the ACS contained in a commercial BMP-2 kit.
To confirm the facilitation of fracture healing, we used a rat femur osteotomy model with a gap of 1 mm. Rat osteotomy models have been used in many studies with various fixation methods, such as intramedullary pin, external fixator, and plate fixation. [20] [21] [22] [23] [24] [25] A defect size over 4 mm has generally been regarded as the critical size at which intervention is required for bone regeneration. However, in cases where the defect size is less than 2 mm, whether or not the defect can heal spontaneously depends on the conditions of the osteotomy site and fixation. 21, 23, 24 In a previous study, a rat femur osteotomy with a 2-mm bone defect fixed using an external fixator scarcely showed bone union. 23 In contrast, a femur osteotomy model with a 1-mm bone defect fixed using an external fixator demonstrated spontaneous union in all cases. 21 However, even in the case of a small defect (0.5 mm) with an external fixator, when the bone marrow and periosteum at the bone stumps were removed, all cases showed nonunion and some cases even demonstrated atrophy of the bone stumps. 24 In our study, no femurs in the control group achieved bone union. In surgery, to preserve the bioactivity of the osteotomy sites, cooling by irrigation with natural saline was performed, and the plate fixation with steel band wiring was sufficiently rigid such that mobility of the osteotomy site was not detected by the manual palpation at 8 weeks post-surgery, even in the control group. Therefore, negative factors for bone union such as reduction of bioactivity and instability at the osteotomy sites were not detected in our procedure. To the best of our knowledge, most rat osteotomy models have utilized bone defects with critical sizes, and relatively few reports have addressed small defects; we could not find an osteotomy model with a defect of 1 mm using plate fixation in the literature. Although the reasons for the poor results in the control group are unclear, we have two speculations as follows. One possible reason for the poor results in the control group was the use of large Kirschner wires with a diameter of 1.4 mm, which occupied the majority of the bone FRACTURE HEALING BY HAp/COL 133 marrow cavity and may have suppressed the supply of progenitor cells that contribute to bone union, resulting in non-union as indicated by a previous report. 24 Another possible reason was the excessive rigidity of the fixation. In contrast to the plate fixation system used in our study that achieved rigid fixation, external fixation permits certain levels of mobility at the osteotomy site, although the mobility depends on length of offset, diameter of the wires and materials. 21, 26 Given our result that 1-mm bone defects fixed with the plate system did not heal spontaneously together with a previous report of fusion for all bone defects fixed using an external fixation system, 21 we speculate that the high stability of the fixation in our study may have resulted in the lack of union. Regardless of the reason, we can only conclude that the control group in our study could not achieve bone union, that is, that our osteotomy model is a stable non-union model, even though we had expected it to be a spontaneously healing model when we were planning the experiments.
In the HAp/Col group, the quantity of formed bone at the osteotomy site was higher than that of the control group. This result indicates an augmentation of bone formation, although only two cases achieved bone union. The efficacy of HAp/Col alone for healing general fractures was not determined because of the lack of bone union in the experimental model, as described above.
All cases in the HAp/Col þ BMP-2 group achieved bone union, and the mechanical strength was comparable to that of intact femurs. BMP-2 is known to have potent osteoinductivity and can form bone tissue, even in muscles. Therefore, the BMP-2 contained in the paste might induce bone formation by recruiting osteogenic cells not only from the bone marrow or periosteum but also from surrounding muscle tissue. This osteoinductivity is considered to be a great advantage, especially in an experimental model in which bone marrow cell recruitment might be restricted.
The fusion rate in the HAp/Col þ BMP-2 group was higher than that in the ACS þ BMP-2 group. HAp/Col has a large specific surface of HAp crystals (75 m 2 /g), which have high affinity for BMP-2. As a result, HAp/ Col can bind a large amount of BMP-2 (3.33 mg/g), even in FBS, which contains various proteins that also have affinity for HAp. Furthermore, the release of BMP-2 from HAp/Col in FBS was sustained, and 70% of the maximum adsorbed dose was retained on HAp/ Col even after 5 days. We had also assessed BMP-2 release from ACS in FBS in another study (unpublished data), and most of the BMP-2 that infiltrated the ACS was re-released promptly after immersion in FBS. Therefore, the higher fusion rates observed in the HAp/Col þ BMP-2 group compared to the ACS þ BMP-2 group could be ascribed to not only the osteoconductivity of HAp/Col observed in the HAp/Col group but also the adsorptive characteristics of HAp/ Col as a BMP carrier. The adsorption of BMP-2 to HAp/Col would be effective not only for sustaining the effect of BMP-2 but also for preventing complications caused by excessive concentrations of BMP-2. A clinical study using BMP-7 combined with a bovine collagen carrier reported that 18% of the cases showed heterotopic ossification that was probably induced by unregulated release of BMP-7. 27 Heterotopic ossification can cause serious complications, especially when occurring adjacent to nerve tissue. 28 However, BMPs cannot be effective without appropriate release. Using PLA/PGA composite carriers that would not release BMP without degradation of the carriers, Saito et al. demonstrated that appropriate degradation was critical for osteoinduction by BMP, 29 and furthermore that enhanced degradation of the carrier by addition of pdioxanone augmented the osteoinduction capability of the composite. 30 As shown in the in vitro BMP release study, 19 HAp/Col can retain BMP-2 for long periods. However, transplanted HAp/Col is resorbed by osteoclasts or osteoclast-like macrophages, and therefore, we speculate that the resorption of HAp/Col by these cells released the BMP-2 adsorbed on the HAp/Col.
Although we used a dried HAp/Col paste in this study, an additional clinical advantage of the HAp/Col paste is that it is injectable, in contrast to ACS or other bone substitutes. Therefore, the HAp/Col paste with or without BMP-2 could also be applied to fractures without surgery. However, to demonstrate the efficacy of the HAp/Col paste with or without BMP-2 for general fractures that can be treated conservatively, the effects should be evaluated in an osteotomy or fracture model in which bone union is easily achieved. In this study, the rat femur osteotomy model unexpectedly showed non-union in the control condition. Therefore, we were not able to evaluate the efficacy of the HAp/Col paste in a common fracture that would heal spontaneously. Additionally, considering the cost of the combined use of HAp/Col and BMP-2, cases of delayed union, pseudoarthrosis, or fracture with large bone defects should be targeted for this treatment. Therefore, for clinical use, the efficacy of the treatment should be confirmed using a non-union model or a large bone defect model. These are considered to be the limitations of the present study, although it should also be noted that collectively, our findings show that the combination of HAp/Col and BMP-2 used here enabled union to occur in a nonunion model. We believe that there may be concerns about the HAp/Col paste used in this study. The paste was a simple mixture of HAp/Col fibers and natural saline. Therefore, the implanted paste might physically disperse, and the effects of the paste might diminish earlier than expected. Furthermore, adjustment of the viscosity for favorable injection and retention at the implant site is difficult because of the combination of HAp/Col fibers and natural saline. The addition of a binder may be effective for retention of the HAp/Col paste and its sustained effect. We believe that fibrinogen found in blood plasma could be a candidate because autologous plasma can be easily prepared by blood collection and centrifugation. Addition of calcium ions to fibrinogen included in blood plasma mixed with a chelating agent can form a fibrin gel within minutes. , and HAp/ Col þ BMP-2 groups, respectively. The scale bar represents 2 mm. In A and B, the invasion of fibrous tissue into the osteotomy sites and bone marrow cavity was confirmed. In the B, normal bone marrow was observed at the left side of the bone marrow cavity (asterisk). In C and D, the osteotomy site was bridged by crude bone tissue, and cracks caused by the biomechanical test (black arrow heads) were also observed. At the osteotomy site, normal bone marrow had recovered (asterisk) although fibrous tissue remained at the right side of the bone marrow cavity in the ACS þ BMP-2 group. E and F: Larger images of the rectangular areas in B and C, respectively. The scale bar represents 500 mm. In E, cartilage tissue, which indicates endochondral ossification, is also confirmed, connecting to the newly formed bone in the bone marrow cavity (white arrow heads).
FRACTURE HEALING BY HAp/COL Furthermore, fibrin gel has a hemostatic effect that may be beneficial for recent fractures.
In conclusion, we found that HAp/Col paste combined with BMP-2 significantly augmented the bone fusion rate, and HAp/Col alone also augmented bone formation at osteotomy sites, but this effect was not sufficient for bone union in the experimental model used in this study. From these results, we expect that the HAp/Col paste will accelerate fracture healing, and that addition of BMP-2 to HAp/Col paste will provide further acceleration. Furthermore, because injectable scaffolds can be applied to various fracture sites without surgery, the HAp/Col paste as an injectable product might be a promising candidate tool to enhance fracture healing.
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